You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

EVEREST

Showing 1 - 25 of 95
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neovascular (Wet) Age-related Macular Degeneration (nAMD) Trial (EXG102-031)

Not yet recruiting
  • Neovascular (Wet) Age-related Macular Degeneration (nAMD)
  • EXG102-031
  • (no location specified)
Jun 13, 2023

EVEREST-HN 1: EVolution ofpatiEnt-REported Symptom-based Risk

Recruiting
  • Head and Neck Cancer
  • No intervention.
  • Leeds, United Kingdom
  • +3 more
Jun 14, 2023

Treatment Resistant Disorders, Post Traumatic Stress Disorder Trial in Windsor (Psilocybin)

Not yet recruiting
  • Treatment Resistant Disorders
  • Post Traumatic Stress Disorder
  • Windsor, Nova Scotia, Canada
    Halucenex Life Sciences Inc.
Jul 27, 2022

Fusion Rate Using K2M VESUVIUS® Demineralized Fibers With K2M

Terminated
Has Results
  • Spinal Stenosis
  • +2 more
    • (no location specified)
    Feb 9, 2021

    Nausea, Vomiting, Childhood Cancer Trial in Oklahoma City (Ondansetron, dexamethasone, aprepitant, Ondansetron, Dexamethasone, )

    Completed
    • Nausea
    • +2 more
    • Ondansetron, dexamethasone, aprepitant
    • Ondansetron, Dexamethasone, placebo
    • Oklahoma City, Oklahoma
      Jimmy Everest Center for Cancer and Blood Disorders in Children
    Mar 18, 2021

    Hemophilia A With Inhibitors, Hemophilia B With Inhibitors Trial in Worldwide (Coagulation FVIIa (Recombinant))

    Completed
    Has Results
    • Hemophilia A With Inhibitors
    • Hemophilia B With Inhibitors
    • Coagulation FVIIa (Recombinant)
    • Aurora, Colorado
    • +8 more
    Feb 24, 2022

    Cardiac Arrhythmias at Extreme Altitude

    Recruiting
    • Arrhythmias, Cardiac
    • +3 more
    • Ambulatory rhythm recording
    • Kathmandu, Nepal
      National Academy of Medical Sciences, Bir Hospital
    Jan 13, 2023

    Fatigue, End Stage Kidney Disease, Quality of Life Trial (Energy conservation education intervention for people with end-stage

    Unknown status
    • Fatigue
    • +2 more
    • Energy conservation education intervention for people with end-stage kidney disease receiving hemodialysis
    • (no location specified)
    Apr 23, 2020

    Pediatric Cancer, Solid Tumors, Lymphoma Trial in Oklahoma City (Eribulin mesylate)

    Terminated
    • Pediatric Cancer
    • +2 more
    • Eribulin mesylate
    • Oklahoma City, Oklahoma
      Jimmy Everest Center for Cancer and Blood Disorders in Children
    Mar 6, 2020

    Plexiform Neurofibroma, Neurofibromatosis Type 1 (NF1) Trial in United States (Mirdametinib (PD-0325901) oral capsule or

    Active, not recruiting
    • Plexiform Neurofibroma
    • Neurofibromatosis Type 1 (NF1)
    • Mirdametinib (PD-0325901) oral capsule or dispersible tablet
    • Birmingham, Alabama
    • +49 more
    Nov 17, 2022

    Phantom Limb Pain Trial (device, behavioral, other)

    Not yet recruiting
    • Phantom Limb Pain
    • M1 anodal home-based tDCS
    • +2 more
    • (no location specified)
    Jun 14, 2022

    Primary Membranous Nephropathy Trial (EVER001)

    Not yet recruiting
    • Primary Membranous Nephropathy
    • (no location specified)
    Mar 23, 2023

    Solid Tumor, Adult, Solid Tumor, Pancreatic Cancer Trial in United States (A2B530, xT-Onco with HLA-LOH Assay)

    Not yet recruiting
    • Solid Tumor, Adult
    • +15 more
    • A2B530
    • xT-Onco with HLA-LOH Assay
    • Duarte, California
    • +6 more
    Feb 10, 2023

    SARS-CoV-2 Infection Trial (PTX-COVID19-B, Vaxzevria®)

    Not yet recruiting
    • SARS-CoV-2 Infection
    • PTX-COVID19-B
    • Vaxzevria®
    • (no location specified)
    Sep 7, 2022

    Solid Tumor, Adult, Colorectal Cancer, NSCLC Trial in United States (A2B694, xT CDx with HLA-LOH Assay)

    Not yet recruiting
    • Solid Tumor, Adult
    • +19 more
    • A2B694
    • xT CDx with HLA-LOH Assay
    • Duarte, California
    • +9 more
    Sep 22, 2023

    SARS-CoV-2 Infection Trial (PTX-COVID19-B, Comirnaty®)

    Not yet recruiting
    • SARS-CoV-2 Infection
    • PTX-COVID19-B
    • Comirnaty®
    • (no location specified)
    Sep 7, 2022

    Primary IgA Nephrology Trial in Beijing (Nefecon)

    Not yet recruiting
    • Primary IgA Nephrology
    • Beijing, Beijing, China
      Peking University First Hospital
    Sep 6, 2022

    Acute Heart Failure, Diuretic Resistance Trial (Furosemide, Metolazone, Acetazolamide)

    Not yet recruiting
    • Acute Heart Failure
    • Diuretic Resistance
    • (no location specified)
    Aug 8, 2023

    Metastatic Breast Cancer Trial in China, Korea, Republic of, Taiwan (sacituzumab govitecan (IMMU-132), Eribulin Mesylate

    Recruiting
    • Metastatic Breast Cancer
    • sacituzumab govitecan (IMMU-132)
    • +4 more
    • Beijing, China
    • +43 more
    Apr 19, 2022

    Acute Kidney Injury Trial in Worldwide (ANG-3777, Placebo)

    Active, not recruiting
    • Acute Kidney Injury
    • Los Angeles, California
    • +39 more
    Jul 9, 2021

    Solid Tumor Trial in Beijing (Sacituzumab Govitecan-hziy)

    Recruiting
    • Solid Tumor
    • Sacituzumab Govitecan-hziy
    • Beijing, Beijing, China
      Beijing Cancer Hospital
    Nov 3, 2021

    Quality of Life of Lymphomas Treated With Oral Therapy

    Recruiting
    • Quality of Life
    • Questionnaire
    • Toulouse 9, France
      Loïc YSEBAERT
    Apr 22, 2022

    Needs in Polypoidal Choroidal Vasculopathy (PCV)

    Recruiting
    • Polypoidal Choroidal Vasculopathy
    • Indocyanine Green Angiography
    • Singapore, Singapore
    • +2 more
    Sep 27, 2021

    Intracranial Hemorrhages, Atrial Fibrillation Trial in Worldwide (Edoxaban, Non-anticoagulant medical therapy)

    Recruiting
    • Intracranial Hemorrhages
    • Atrial Fibrillation
    • Elk Grove Village, Illinois
    • +152 more
    Jan 23, 2023

    Heart Failure Trial in Tehran (Acetazolamide, )

    Not yet recruiting
    • Heart Failure
    • Acetazolamide
    • placebo
    • Tehran, Tehran Heart Center, Iran, Islamic Republic of
      Houshang bavandpour karvane
    Jul 10, 2023